Literature DB >> 25301400

Characterization of human Influenza Viruses in Lebanon during 2010-2011 and 2011-2012 post-pandemic seasons.

Hassan Zaraket1, Clyde Dapat, Soha Ghanem, Zainab Ali, Mireille Lteif, Hiroki Kondo, Isolde C Dapat, Kousuke Saito, Ghazi Kayali, Hiroshi Suzuki, Ghassan Dbaibo, Reiko Saito.   

Abstract

OBJECTIVE: To genetically characterize human influenza viruses and their susceptibilities to antivirals during two post-pandemic seasons in Lebanon.
METHODS: Influenza virus was isolated from nasopharyngeal swabs that were obtained from patients with influenza-like illness during 2010-2012 and further analyzed both phenotypically and genotypically.
RESULTS: During the 2010-2011 season, both 2009 pandemic H1N1 (H1N1p) and B viruses co-circulated with equal prevalence, while the H3N2 virus predominated during the 2011-2012 season. All H3N2 and H1N1 viruses were resistant to amantadine. Importantly, all viruses of the influenza A and B types were susceptible to the neuraminidase (NA) inhibitors oseltamivir, zanamivir, peramivir, and laninamivir. Nonetheless, all 2011-2012 H1N1p isolates had three mutations (V241I, N369K, and N386S) in the NA gene that were suggested to be permissive of the H275Y mutation, which confers resistance to oseltamivir. We also detected one H1N1p virus during the 2010-2011 season with a 4-fold decrease in susceptibility to oseltamivir due to an NA-S247N mutation. This isolate was phylogenetically distinct from other H1N1p viruses that were isolated in other regions.
CONCLUSIONS: Influenza A viruses with reduced susceptibility to oseltamivir and mutations permissive for acquiring NA resistance-conferring mutation with minimal burden on their fitness were isolated in Lebanon.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25301400     DOI: 10.1159/000365758

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  6 in total

1.  Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazil are endowed with permissive mutations, which compensate the loss of fitness imposed by antiviral resistance.

Authors:  Thiago Moreno Lopes e Souza; Natalia Fintelman-Rodrigues; Paola Cristina Resende; Milene Mesquita; Tatiana Schaffer Gregianini; Fernando A Bozza; Ana Carla Pecego; Sandra Bianchini Fernandes; Ana Luisa Furtado Cury; Irina Nastassja Riediger; Marilda M Siqueira
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-27       Impact factor: 2.743

2.  Susceptibility of influenza A(H1N1)/pdm2009, seasonal A(H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014.

Authors:  Shan-Shan Liu; Xiao-Yang Jiao; Sheng Wang; Wen-Zhe Su; Ling-Zhi Jiang; Xin Zhang; Chang-Wen Ke; Ping Xiong
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

Review 3.  A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region.

Authors:  Samira Soudani; Alireza Mafi; Zayid Al Mayahi; Sultan Al Balushi; Ghassan Dbaibo; Salah Al Awaidy; Amine Amiche
Journal:  Infect Dis Ther       Date:  2022-01-08

Review 4.  Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections.

Authors:  Malak M Alame; Elie Massaad; Hassan Zaraket
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

5.  Etiology, seasonality, and clinical characterization of viral respiratory infections among hospitalized children in Beirut, Lebanon.

Authors:  Mayda Finianos; Randi Issa; Martin D Curran; Claude Afif; Maryam Rajab; Jihad Irani; Noha Hakimeh; Amal Naous; Marie-Joelle Hajj; Pierre Hajj; Tamima El Jisr; Mira El Chaar
Journal:  J Med Virol       Date:  2016-05-19       Impact factor: 2.327

6.  The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience.

Authors:  Aia Assaf-Casals; Zeina Saleh; Sarah Khafaja; Danielle Fayad; Hady Ezzeddine; Mohammad Saleh; Sarah Chamseddine; Rouba Sayegh; Sima L Sharara; Ahmad Chmaisse; Souha S Kanj; Zeina Kanafani; Rima Hanna-Wakim; George F Araj; Rami Mahfouz; Reiko Saito; Hiroshi Suzuki; Hassan Zaraket; Ghassan S Dbaibo
Journal:  BMC Infect Dis       Date:  2020-05-12       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.